Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $28.24 million. The enterprise value is $7.40 million.
| Market Cap | 28.24M |
| Enterprise Value | 7.40M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 5.43 million shares outstanding. The number of shares has increased by 118.32% in one year.
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | +118.32% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 11.67% |
| Owned by Institutions (%) | 17.70% |
| Float | 4.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 49.81 |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14, with zero debt.
| Current Ratio | 5.14 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 12.67 |
Financial Efficiency
Return on equity (ROE) is -65.60% and return on invested capital (ROIC) is -91.26%.
| Return on Equity (ROE) | -65.60% |
| Return on Assets (ROA) | -52.40% |
| Return on Capital (ROIC) | -91.26% |
| Revenue Per Employee | $83,319 |
| Profits Per Employee | -$2.04M |
| Employee Count | 7 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.21% in the last 52 weeks. The beta is 0.17, so APRE's price volatility has been lower than the market average.
| Beta (1Y) | 0.17 |
| 52-Week Price Change | +40.21% |
| 50-Day Moving Average | 6.40 |
| 200-Day Moving Average | 4.80 |
| Relative Strength Index (RSI) | 40.97 |
| Average Volume (30 Days) | 33,364 |
Short Selling Information
The latest short interest is 96,178, so 1.77% of the outstanding shares have been sold short.
| Short Interest | 96,178 |
| Short Previous Month | 105,828 |
| Short % of Shares Out | 1.77% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 6.71 |
Income Statement
In the last 12 months, APRE had revenue of $583,231 and -$14.29 million in losses. Loss per share was -$3.95.
| Revenue | 583,231 |
| Gross Profit | 583,231 |
| Operating Income | -15.47M |
| Pretax Income | -14.29M |
| Net Income | -14.29M |
| EBITDA | -15.50M |
| EBIT | -15.51M |
| Loss Per Share | -$3.95 |
Balance Sheet
The company has $21.65 million in cash and no debt, giving a net cash position of $21.65 million or $3.99 per share.
| Cash & Cash Equivalents | 21.65M |
| Total Debt | n/a |
| Net Cash | 21.65M |
| Net Cash Per Share | $3.99 |
| Equity / Book Value | 16.95M |
| Book Value Per Share | 3.12 |
| Working Capital | 18.14M |
Cash Flow
In the last 12 months, operating cash flow was -$12.18 million and capital expenditures -$93,093, giving a free cash flow of -$12.27 million.
| Operating Cash Flow | -12.18M |
| Capital Expenditures | -93,093 |
| Free Cash Flow | -12.27M |
| FCF Per Share | -$3.39 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,652.80% and -2,449.59%.
| Gross Margin | 100.00% |
| Operating Margin | -2,652.80% |
| Pretax Margin | -2,449.59% |
| Profit Margin | -2,449.59% |
| EBITDA Margin | -2,658.27% |
| EBIT Margin | -2,659.48% |
| FCF Margin | -2,103.92% |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -118.32% |
| Shareholder Yield | -118.32% |
| Earnings Yield | -49.18% |
| FCF Yield | -42.24% |
Analyst Forecast
The average price target for APRE is $15.50, which is 198.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 198.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 150.89% |
| EPS Growth Forecast (5Y) | -20.89% |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -17.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.26 |
| Piotroski F-Score | 1 |